Samsung Bioepis Launches Ustekinumab Biosimilar Marking Its First Product Launch in Japan
Ustekinumab BS 45 mg Syringe for S.C. Injection「NIPRO」 is now available in Japan, after its listing under the National Health[…]
Read moreBusiness News travel and leisure
Ustekinumab BS 45 mg Syringe for S.C. Injection「NIPRO」 is now available in Japan, after its listing under the National Health[…]
Read more
MONTREAL–(BUSINESS WIRE)–May. 12, 2026 Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich,[…]
Read more
Medytox Global Anatomy Workshop drew over 350 medical professionals from Taiwan, Japan, and Thailand. Medytox joined the ICLAS 2026 industrial[…]
Read more
Aiming to Develop New Gut Microbiota Test Items and a Personalized Food Recommendation Algorithm TOKYO & YAMAGATA, Japan–(BUSINESS WIRE)–Feb. 27,[…]
Read more
Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial[…]
Read more
IRVINE, Calif.–(BUSINESS WIRE)–Aug. 13, 2025 Insert after the second paragraph, 9th bullet: First Half 2025 Highlights. The updated release reads: […]
Read more
The Well Estate will provide a turnkey solution for hospitality asset owners to be able to offer transformative medical wellness[…]
Read more
PLATTSBURGH, N.Y.–(BUSINESS WIRE)–Jun. 10, 2025 Medisca and FlackTek have reached a settlement to resolve their patent dispute relating to the[…]
Read more
Medical Korea 2025 to be held from March 20 (Thu) to March 23 (Sun), 2025, at COEX in Seoul, South[…]
Read more
Launched 14 critical injectable medicines since Company inception in October 2023 and remains on track to meet target of 25+[…]
Read more